Science Explorer Back to mapMap
Institution · Otemae Hospital

Most cited papers from Otemae Hospital

What are the most cited papers from Otemae Hospital?

The most cited paper from Otemae Hospital is "Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth" (Rajesh Ramasamy, Eric W.‐F. Lam, Inês Soeiro et al., 2006), with 409 citations. Next come "Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients." (350) and "Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia" (305).

Showing 50 of 60 papers. Every paper with more than 64 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth Rajesh Ramasamy, Eric W.‐F. Lam, Inês Soeiro et al. · Leukemia Open access 14 Dec 2006 409
2 Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. Naoto Itoh, Toshiaki Hanafusa, Atsushi Miyazaki et al. · Journal of Clinical Investigation Open access Nov 1993 350
3 Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia ZiYi Lim, Ronald Brand, Rodrigo Martino et al. · Journal of Clinical Oncology Open access 15 Dec 2009 305
4 The Structure and Pharmacological Functions of Coumarins and Their Derivatives Lin Wu, Xiaohong Wang, Xu Wei et al. · Current Medicinal Chemistry 10 Oct 2009 289
5 Variations in the FTO gene are associated with severe obesity in the Japanese Kikuko Hotta et al. · Journal of Human Genetics Open access 31 Mar 2008 246
6 Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) Shinji Atagi, Masaaki Kawahara, Akira Yokoyama et al. · The Lancet Oncology 22 May 2012 240
7 Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes Arjan A. van de Loosdrecht et al. · Haematologica Open access 22 Jun 2009 239
8 Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial Giorgio V. Scagliotti et al. · The Lancet Respiratory Medicine 15 May 2019 167
9 Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis Atsushi Hiraoka et al. · Cancer Medicine Open access 24 May 2019 159
10 Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection Kentaro Matsuura et al. · Gastroenterology Open access 3 Feb 2017 156
11 Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor Clemens L. Bockmeyer, Ralf Alexander Claus, Ulrich Budde et al. · Haematologica Open access 31 Dec 2007 148
12 A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cells Stefan Carlens, Mari Gilljam, Benedict J. Chambers et al. · Human Immunology Oct 2001 143
13 Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population Kikuko Hotta et al. · Journal of Human Genetics 23 Oct 2009 143
14 Two decades of annual medical examinations in Japanese obese children: Do obese children grow into obese adults? Kazuaki Kotani, M. Nishida, Shizuya Yamashita et al. · International Journal of Obesity Oct 1997 143
15 Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats Yuka Shimeda, Yoshihiko Hirotani, Youko Akimoto et al. · Biological and Pharmaceutical Bulletin Open access 2005 139
16 Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population Andrea Casadei Gardini et al. · European Journal of Cancer Open access 25 Nov 2022 135
17 Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis Margherita Rimini et al. · ESMO Open Open access 5 Oct 2022 132
18 Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis Atsushi Hiraoka et al. · Cancer Medicine Open access 21 Dec 2018 132
19 Morphological evaluation of monocytes and their precursors Jean-Etienne Goasguen, John M. Bennett, Barbara Jane Bain et al. · Haematologica Open access 16 Jun 2009 130
20 Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma Yoshikazu Morimoto, Yasuhiro Tanaka, Toshinori Ito et al. · Journal of Hepato-Biliary-Pancreatic Surgery Dec 2003 128
21 Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial Hirohisa Saito, Hirohisa Yoshizawa, Kozo Yoshimori et al. · Annals of Oncology Open access 2 Nov 2012 119
22 Resistive index predicts renal prognosis in chronic kidney disease Takashi Sugiura, Akira Wada · Nephrology Dialysis Transplantation 23 Mar 2009 115
23 Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation Shahryar Kiaii, Andrew James Clear, Alan G. Ramsay et al. · Journal of Clinical Oncology Open access 17 Jun 2013 112
24 Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease Giovanni Pizzolo, Marco Chilosi, Fabrizio Vinante et al. · British Journal of Cancer Open access Apr 1987 112
25 Low‐frequency subthalamic nucleus stimulation in Parkinson's disease: A randomized clinical trial Hui Ming Khoo, Haruhiko Kishima, Koichi Hosomi et al. · Movement Disorders 21 Jan 2014 106
26 The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review Simone Oerlemans, Floortje Mols, Marten R. Nijziel et al. · Annals of Hematology ReviewOpen access 13 Jun 2011 100
27 4G/5G Polymorphism of PAI-1 Gene Promoter and Fibrinolytic Capacity in Patients with Deep Vein Thrombosis Maria Teresa Sartori, Björn Wiman, Silvia Vettore et al. · Thrombosis and Haemostasis 1998 99
28 Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study The Japan Adult Leukemia Study Group et al. · International Journal of Hematology 19 Sep 2017 98
29 Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib Toshifumi Tada et al. · Liver International Open access 17 Feb 2020 97
30 Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population Mayumi Kasahara, Kayo Osawa, Kana Yoshida et al. · Journal of Experimental & Clinical Cancer Research Open access 30 Sep 2008 94
31 Comparison of performances of artificial intelligence versus expert endoscopists for real-time assisted diagnosis of esophageal squamous cell carcinoma (with video) Hiromu Fukuda, Ryu Ishihara, Yusuke Kato et al. · Gastrointestinal Endoscopy Open access 4 Jun 2020 92
32 Cortical excitability changes after high-frequency repetitive transcranial magnetic stimulation for central poststroke pain Koichi Hosomi, Haruhiko Kishima, Satoru Oshino et al. · Pain 16 Apr 2013 91
33 Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases Fumi Sato, Norikazu Maeda, Takayuki Yamada et al. · Circulation Journal Open access 26 Sep 2017 90
34 Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription Andrea G.S. Buggins, Chris J. Pepper, Piers Patten et al. · Cancer Research 24 Aug 2010 89
35 Effect of Surgical Removal on Survival and Quality of Life in Patients With Supratentorial Glioblastoma Yukitaka Ushio, Masato Kochi, Jun-ichiro Hamada et al. · Neurologia medico-chirurgica Open access 2005 88
36 Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer Junichi Hasegawa, Junichi Nishimura, Tsunekazu Mizushima et al. · Cancer Chemotherapy and Pharmacology 4 Mar 2014 87
37 Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins. Nicola Brady, Terry J. Gaymes, Manyee Cheung et al. · PubMed 15 Apr 2003 85
38 The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation Pia Raanani, Francesco Dazzi, Jastinder Sohal et al. · British Journal of Haematology Open access Dec 1997 85
39 Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study Takeshi Hatanaka et al. · Hepatology International 24 Jun 2022 84
40 Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma Atsushi Hiraoka et al. · Oncology 2019 83
41 Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome Azim M. Mohamedali, Alexander Smith, Joop A. Gäken et al. · Journal of Clinical Oncology 16 Jun 2009 82
42 Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice Takaaki Tanaka et al. · Hepatology Research Open access 28 May 2022 79
43 Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population Kikuko Hotta et al. · Journal of Human Genetics Open access 28 Jul 2011 76
44 Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma Ayuko Saeki, Shinji Tamura, Nobuyuki Ito et al. · Cancer 28 Mar 2002 76
45 Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors Frits van Rhee, David G. Savage, Jillian Blackwell et al. · Bone Marrow Transplantation Open access May 1998 75
46 Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease Wataru Sako, Masami Nishio, Tomoyuki Maruo et al. · Movement Disorders 7 Apr 2009 75
47 Multicenter, phase II, placebo‐controlled, double‐blind, randomized study of aprepitant in Japanese patients receiving high‐dose cisplatin Toshiaki Takahashi, Eishin Hoshi, Masakazu Takagi et al. · Cancer Science Open access 24 Jul 2010 73
48 Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis Yoshihiro Kamada et al. · PLoS ONE Open access 21 Jun 2013 73
49 Rapid Evolution of Yeast Centromeres in the Absence of Drive Douda Bensasson, Magdalena Zarowiecki, Austin Burt et al. · Genetics Open access Apr 2008 71
50 Bilateral pallidal deep brain stimulation in primary Meige syndrome Wataru Sako, Ryoma Morigaki, Yoshifumi Mizobuchi et al. · Parkinsonism & Related Disorders 14 Dec 2010 71

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.